Carrie L. Bourdow Trevena Inc (TRVN) insider trading activity

Carrie L. Bourdow is Acting CEO of TREVENA INC. Currently has a direct ownership of 23,894 shares of TRVN, which is worth approximately $42,292. The most recent transaction as insider was on Oct 08, 2024, when has been sold 1,822 shares (Common Stock) at a price of $1.47 per share, resulting in proceeds of $2,678. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.9K

0% 3M change

96.28% 12M change

Total Value Held $42,292

Carrie L. Bourdow Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 08 2024	SELL Payment of exercise price or tax liability	$2,678 $1.47 p/Share	1,822 Reduced 7.09%	23,894 Common Stock
Dec 14 2023	SELL Payment of exercise price or tax liability	$4,345 $0.61 p/Share	7,123 Reduced 1.1%	642,923 Common Stock
Dec 14 2023	BUY Grant, award, or other acquisition	$286,700 $0.61 p/Share	470,000 Added 41.96%	650,046 Common Stock
Dec 02 2023	SELL Payment of exercise price or tax liability	$7,096 $0.59 p/Share	12,028 Reduced 6.26%	180,046 Common Stock
Jan 06 2023	BUY Grant, award, or other acquisition	-	100,000 Added 34.24%	192,074 Common Stock
Dec 17 2022	SELL Payment of exercise price or tax liability	$2,080 $1.55 p/Share	1,342 Reduced 1.44%	92,074 Common Stock
Dec 02 2022	SELL Payment of exercise price or tax liability	$12,175 $3.42 p/Share	3,560 Reduced 3.67%	93,416 Common Stock
Dec 17 2021	SELL Payment of exercise price or tax liability	$23,482 $0.7 p/Share	33,546 Reduced 1.36%	2,424,403 Common Stock
Dec 06 2021	SELL Payment of exercise price or tax liability	$60,815 $0.65 p/Share	93,561 Reduced 3.67%	2,457,949 Common Stock
Dec 02 2021	BUY Grant, award, or other acquisition	-	1,250,000 Added 32.88%	2,551,510 Common Stock
Jun 28 2021	BUY Open market or private purchase	$100,598 $1.79 p/Share	56,200 Added 4.14%	1,301,510 Common Stock
Dec 17 2020	BUY Grant, award, or other acquisition	-	471,100 Added 27.15%	1,264,060 Common Stock
Dec 07 2020	SELL Payment of exercise price or tax liability	$301,760 $2.27 p/Share	132,934 Reduced 14.36%	792,960 Common Stock

Also insider at

SESN

Sesen Bio, Inc. Healthcare

Director

NBRV

Nabriva Therapeutics plc Healthcare

Director

CLB

Carrie L. Bourdow

Acting CEO

Fort Washington, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRVN shares.

Notify only if

Value

Insider Trading

Get notified when an Trevena Inc insider buys or sells TRVN shares.

Notify only if

Operation

Value

Type

News

Receive news related to TREVENA INC

Track Activities on TRVN

Account